Male or female patients aged ?18 years
Female aged ? 18 years.
Male or female patients aged ? 18 years.
Female subject aged ? 18 years.
Male or female aged ? 18 years
Adult male or female participants aged >=20 years (Japan) or >=18 years (United States).
Male or female patients aged ? 18 years at time of informed consent;
Male or female aged ? 18 years;
Male or female aged ?18 years.
Male or female, aged at least 18 years.
Female, aged ?18 years
Male or female subjects aged greater than or equal to (>=) 18 years
Male or female subjects aged ?18 years
Male or non-pregnant, non-breastfeeding female at least 18 years of age. Patients aged at 12~18 years may be recruited but only at the site principle investigator's request and subject to IRB approval.
Male or female aged at least 18 years. Aged at least 20 if Japanese.
Male patient aged, equal to, or more than,18 years old.
Male or female patients aged 18 - 75 years.
Male or female subjects aged greater than or equal to (>=) 18 years
Male or female subjects aged ?18 years
Subjects may be male or female, and must be aged =/>18 years on the date of signing the informed consent form.
Male or female subjects aged ?18 years
Male or female subjects aged >/= 18 years.
Patient is male or female aged ?18 years.
Male or female, aged at least 18 years.
Male or female subjects aged greater than or equal to (>=) 20 years
Male and female subjects aged greater than 18 years
Male or female patients aged >/= 18 years old
Male or female participants aged ?18 years at the time of screening
Male or female subjects aged > 18 years
Male and female subjects aged 1 to 18 years, inclusive.
Male or female aged ? 18 years
Male or female subjects aged ?18 years (or country-specific legal age of maturity, if >18 years)
Male or female subjects aged =/> 18 years
Male or female subjects aged >/=18 years
Male or female aged ? 18 years
Male or female subjects aged >/=21 years
Male and female patients aged ? 18 years.
Male or female participants aged 2 to <18 years (5 to <18 years for Hodgkin lymphoma [HL])
Male or female aged 16 years; a female is eligible to enter and participate in the study if she is:
Male or female patients aged >18 years
Male and female patients aged 18 to 70 years, inclusive;
Female aged ?18 years of age.
Male or female, age ? 18 years and ? 70 years. Patients aged ? 65 years must have a Sorror score ? 3
Male or female aged 18-79
